Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Effects of Afatinib on ORR and DCR in 22 patients.
| Systemic tumor response to treatment (n = 22) | |
|---|---|
| ORR, % (95% CI) | 38.4 (15.2, 59.3) |
| DCR, % (95% CI) | 78.5 (60.8, 97.8) |
| Complete response, n (%) | 0 (0.0) |
| Partial response, n (%) | 8 (35.7) |
| Stable disease, n (%) | 12 (57.4) |
| Progressive disease, n (%) | 5 (15.9) |
Kaplan-Meier analysis on 22 patients treated with Afatinib and conventional DDP+PEM for the relationship between Afatinib and prognosis, ORR, and DCR in patients with NSCLC.
